Authors

Medicare Part D Phase 2 Price Negotiations Target Semaglutide (Wegovy) Plus 14 More Medications

Price negotiations, effective in 2027, cover drugs for diabetes, cancer, COPD, and more, aiming for substantial Medicare savings.

Long COVID's Long Road: A Year 5 Update with Noah Greenspan DPT, PT, CCS, EMT-B

Five years after the COVID-19 pandemic was declared, the protean syndrome dubbed long COVID continues to affect millions; Greenspan is dedicated to helping.

Prenatal Exposure to Antibiotics May Increase Risk for Long-Term Health Problems in Children

The potential adverse outcomes include asthma, food allergies, cerebral palsy, and cancer, according to a recent systematic review and meta-analysis.

Post Traumatic Stress Disorder: Mechanisms of Disease

ACT EARLY, ACT NOW: A Practical Guide to Early Identification of Alzheimer’s Disease

Cognitive Aging Research Program Reveals Insights Based on 25 Years of Data

A 25-year study of the Lothian Birth Cohorts found that childhood intelligence, lifestyle factors, and brain health significantly impact cognitive aging and longevity.

HHS Secretary RFK, Jr, Cancels July 10 USPSTF Meeting, Prompting Fear Across Primary Care Professional Groups

The abrupt cancellation, without warning or cause, has medical groups and health care leaders concerned about patient access to no-cost preventive services.

RFK Jr Ends COVID-19 Vaccine Recommendation for Healthy Children, Pregnant Women

HHS Secretary Kennedy announced the CDC will no longer recommend vaccination against infection with SARS-CoV-2 for the 2 vulnerable populations.

Caregiver Education on Alzheimer Agitation Is Essential: A Q&A with Geriatric Nurse Practitioner Carolyn Clevenger

Clevenger explains how better recognition of agitation in Alzheimer disease, and stronger caregiver–clinician communication, can meaningfully improve outcomes.